Cannabiz co-founder Martin Lane and editor-at-large Rhys Cohen are back with their take on the week’s cannabis news, including:

  • Who to blame for this week’s media coverage of over-the-counter CBD
  • What the Narcotic Drugs Amendment Bill means for the Australian industry
  • Where the next US$7.2 billion cannabis company will come from
  • And what David Beckham could learn from the Cannabiz team’s skincare regime

Join the Conversation

1 Comment

Your email address will not be published. Required fields are marked *

  1. Thanks guys. Interesting discussion. Didn’t know about Jazz pharma buy out of GW. Any link with Entoura/Incannex? Seems they have similar research interests in sleep disorders and BMT.